Viewing StudyNCT00440479



Ignite Creation Date: 2024-05-05 @ 5:24 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00440479
Status: COMPLETED
Last Update Posted: 2015-04-16
First Post: 2007-02-26

Brief Title: ADVANCE An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-4950 Clinical Studies
Sponsor: Janssen-Cilag BV
Organization: Janssen-Cilag BV

Conditions & Keywords Data

Conditions:
Name
Hematological Neoplasms
Multiple Myeloma
Keywords:
Name View
Multiple Myeloma View
hematological neoplasms View
chemotherapy View
efficacy View
safety View
bortezomib View
proteasome inhibitor View